.png){kind=icon}
J
Johannes Oldenburg
H-index:81
Citation Count:2.7万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors
FRONTIER5：从emicizumab直接转换为denecimig（Mim8）在有无抑制剂的血友病A患者中的安全性与患者体验
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins
AI赋能的靶向癌细胞表面蛋白的迷你结合物的发现与生化优化
Nature Communications
IF15.7
In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway
体内和体外THBD和PROCR多态性对蛋白C通路抗凝反应的影响
Blood Advances
IF7.1
Proof of concept for aqueous two-phase system-based extraction of cell-free DNA from plasma for liquid biopsy applications
基于水相双系统提取血浆中游离DNA的概念验证研究，用于液体活检应用
Scientific Reports
IF3.9
Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophilia
评估凝血因子浓缩物预防治疗：严重血友病儿童年化出血率的参考数据
Haematologica
IF7.9
A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A
A-SURE：重组凝血因子VIII Fc融合蛋白与标准半衰期凝血因子VIII在血友病A中的预防性治疗效果的个体内比较
Hematology
IF1.6
Pain diagnostics in people with haemophilia (PwH) - Pressure pain thresholds (PPT) and influence of age and joint status
血友病患者（PwH）的疼痛诊断——压力痛阈（PPT）及年龄和关节状态的影响
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI Activity
理解先天性FXI缺乏症：基因诊断及变异检出率与因子XI活性的相关性
HAMOSTASEOLOGIE
IF2.4
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia A
艾美珠单抗的持续生存获益及获得性血友病A中免疫抑制治疗的推迟
Blood Advances
IF7.1
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy
真实世界中，rIX-FP和rFIXFc用于男性血友病B的预防治疗效果：基于德国和意大利医疗图表数据的合并分析
Standardization of FVIII neutralization for functional Emicizumab Quantification in Presence of Various FVIII Sources
FVIII中和标准化的功能性emicizumab定量在不同FVIII来源存在下
Langerhans Cell Modulation in Atopic Dermatitis Is TLR2/SOCS1-Dependent and JAK Inhibitor-Sensitive
特应性皮炎中朗格汉斯细胞的调控依赖于TLR2/SOCS1，且对JAK抑制剂敏感。
Allergy
IF12
Efficacy and Safety of rVIII-SingleChain in Surgical Prophylaxis
rVIII-SingleChain在手术预防中的有效性与安全性
HAEMOPHILIA
IF3
Profiling of Anti-FVIII Antibodies in Acquired Haemophilia A: 'Insights into Domain Specificity, Isotype Variability, and Clinical Correlations'
获得性血友病A中抗FVIII抗体的分析：对结构域特异性、亚型变异及临床相关性的见解
HAEMOPHILIA
IF3
